Clinical trialNCT03514641CompletedPhase 2/PHASE3Interventional

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

SponsorTheracosEnrollment673Essential Hypertension

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This integrated assessment consists of two studies, 603A and 603B, to be carried out sequentially in a common study population. Participating subjects informed of the trial design and their consent to participate in both studies were to be obtained in a single consent form. Approximately 680 male or female adult subjects were to be enrolled.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew Allegretti, M.D.
Massachusetts General Hospital
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

87 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clinical Research Site
Birmingham, Alabama, United States
Clinical Research Site
Birmingham, Alabama, United States
Clinical Research Site
Birmingham, Alabama, United States
Clinical Research Site
Foley, Alabama, United States
Clinical Research Site
Gulf Shores, Alabama, United States
Clinical Research Site
Glendale, Arizona, United States
Clinical Research Site
Mesa, Arizona, United States
Clinical Research Site
Phoenix, Arizona, United States
Clinical Research Site
Tucson, Arizona, United States
Clinical Research Site
Anaheim, California, United States
Clinical Research Site
Bellflower, California, United States
Clinical Research Site
Fair Oaks, California, United States
Clinical Research Site
Fresno, California, United States
Clinical Research Site
Lincoln, California, United States
Clinical Research Site
Los Angeles, California, United States
Clinical Research Site
San Gabriel, California, United States
Clinical Research Site
Santa Rosa, California, United States
Clinical Research Site
Upland, California, United States
Clinical Research Site
Colorado Springs, Colorado, United States
Clinical Research Site
Colorado Springs, Colorado, United States
Clinical Research Site
Denver, Colorado, United States
Clinical Research Site
Golden, Colorado, United States
Clinical Research Site
Stamford, Connecticut, United States
Clinical Research Site
Decatur, Georgia, United States
Clinical Research Site
Decatur, Georgia, United States
Clinical Research Site
Lithonia, Georgia, United States
Clinical Research Site
Chicago, Illinois, United States
Clinical Research Site
Chicago, Illinois, United States
Clinical Research Site
Chicago, Illinois, United States
Clinical Research Site
Avon, Indiana, United States
Clinical Research Site
Evansville, Indiana, United States
Clinical Research Site
Indianapolis, Indiana, United States
Clinical Research Site
Council Bluffs, Iowa, United States
Clinical Research Site
Prairie Village, Kansas, United States
Clinical Research Site
Lexington, Kentucky, United States
Clinical Research Site
Paducah, Kentucky, United States
Clinical Research Site
Versailles, Kentucky, United States
Clinical Research Site
New Orleans, Louisiana, United States
Clinical Research Site
Auburn, Maine, United States
Clinical Research Site
Silver Spring, Maryland, United States

47 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BexagliflozinPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Oct 2017
Primary completion: 30 Nov 2018
Completion: 30 Nov 2018
Last update posted: 21 Sept 2021
Registered enrollment: 673
Registry id: NCT03514641

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.